A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Seattle Children's Hospital
Seattle Children's Hospital
St. Jude Children's Research Hospital
Medical College of Wisconsin
Instituto do Cancer do Estado de São Paulo